Science Group Bilanço Sağlığı
Finansal Sağlık kriter kontrolleri 6/6
Science Group has a total shareholder equity of £84.5M and total debt of £12.4M, which brings its debt-to-equity ratio to 14.6%. Its total assets and total liabilities are £136.1M and £51.5M respectively. Science Group's EBIT is £9.4M making its interest coverage ratio 64.9. It has cash and short-term investments of £38.8M.
Anahtar bilgiler
14.6%
Borç/özkaynak oranı
UK£12.36m
Borç
Faiz karşılama oranı | 64.9x |
Nakit | UK£38.75m |
Eşitlik | UK£84.52m |
Toplam yükümlülükler | UK£51.54m |
Toplam varlıklar | UK£136.06m |
Son finansal sağlık güncellemeleri
Science Group (LON:SAG) Has A Pretty Healthy Balance Sheet
May 07Is Science Group (LON:SAG) Using Too Much Debt?
Dec 14Recent updates
An Intrinsic Calculation For Science Group plc (LON:SAG) Suggests It's 30% Undervalued
Mar 18Is It Time To Consider Buying Science Group plc (LON:SAG)?
Jun 04Science Group (LON:SAG) Has A Pretty Healthy Balance Sheet
May 07Statutory Profit Doesn't Reflect How Good Science Group's (LON:SAG) Earnings Are
Mar 17Has Science Group plc's (LON:SAG) Impressive Stock Performance Got Anything to Do With Its Fundamentals?
Mar 12Shareholders Of Science Group (LON:SAG) Must Be Happy With Their 172% Total Return
Feb 05Is Science Group (LON:SAG) Using Too Much Debt?
Dec 14Finansal Durum Analizi
Kısa Vadeli Yükümlülükler: SAG's short term assets (£65.0M) exceed its short term liabilities (£32.4M).
Uzun Vadeli Yükümlülükler: SAG's short term assets (£65.0M) exceed its long term liabilities (£19.2M).
Borç-Özkaynak Tarihçesi ve Analizi
Borç Seviyesi: SAG has more cash than its total debt.
Borcun Azaltılması: SAG's debt to equity ratio has reduced from 38.3% to 14.6% over the past 5 years.
Borç Kapsamı: SAG's debt is well covered by operating cash flow (80.7%).
Faiz Kapsamı: SAG's interest payments on its debt are well covered by EBIT (64.9x coverage).